Literature DB >> 15232607

Coagulation-dependent mechanisms and asthma.

Michael A Matthay1, John A Clements.   

Abstract

In several clinical disorders, there are interactions between inflammation-dependent tissue injury and thrombin formation, fibrin deposition, and impaired fibrinolysis. New evidence generated from a mouse model of allergic airway hyperreactivity suggests that disordered coagulation and fibrinolysis may contribute to the pathogenesis of asthma. The inflammatory mechanisms that lead to airway smooth muscle contraction and airway hyperresponsiveness may be associated with accumulation of extravascular fibrin, plasma exudates, and inflammatory cells that can lead to airway closure.

Entities:  

Mesh:

Year:  2004        PMID: 15232607      PMCID: PMC437975          DOI: 10.1172/JCI22288

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant.

Authors:  N N Jarjour; G Enhorning
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

2.  Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma.

Authors:  S H Cho; I P Hall; A Wheatley; J Dewar; D Abraha; J Del Mundo; H Lee; C K Oh
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

3.  Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma.

Authors:  K S Babu; D A Woodcock; S E Smith; J N Staniforth; S T Holgate; J H Conway
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671

Review 4.  New insights into the pathogenesis of asthma.

Authors:  Jack A Elias; Chun Geun Lee; Tao Zheng; Bing Ma; Robert J Homer; Zhou Zhu
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

5.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 6.  Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.

Authors:  Steven Idell
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

Review 7.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis.

Authors:  M Hoshino; M Takahashi; N Aoike
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

9.  Increase of inactive intra-alveolar surfactant subtypes in lungs of asthmatic Brown Norway rats.

Authors:  A Schmiedl; H-G Hoymann; M Ochs; A Menke; A Fehrenbach; N Krug; T Tschernig; J M Hohlfeld
Journal:  Virchows Arch       Date:  2002-11-22       Impact factor: 4.064

Review 10.  Protein C pathway in sepsis.

Authors:  Charles T Esmon
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

View more
  8 in total

1.  Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.

Authors:  Eric K Chu; Jason Cheng; John S Foley; Brigham H Mecham; Caroline A Owen; Kathleen J Haley; Thomas J Mariani; Isaac S Kohane; Daniel J Tschumperlin; Jeffrey M Drazen
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

2.  Role of thrombin-activatable fibrinolysis inhibitor in allergic bronchial asthma.

Authors:  Atsushi Fujiwara; Osamu Taguchi; Takehiro Takagi; Corina N D'Alessandro-Gabazza; Daniel Boveda-Ruiz; Masaaki Toda; Atsushi Yasukawa; Yuki Matsushima; Yasushi Miyake; Hiroyasu Kobayashi; Tetsu Kobayashi; Paloma Gil-Bernabe; Masahiro Naito; Masamichi Yoshida; John Morser; Yoshiyuki Takei; Esteban C Gabazza
Journal:  Lung       Date:  2011-10-25       Impact factor: 2.584

Review 3.  Coagulation and autoimmunity in scleroderma interstitial lung disease.

Authors:  Anna Ludwicka-Bradley; Richard M Silver; Galina S Bogatkevich
Journal:  Semin Arthritis Rheum       Date:  2010-12-17       Impact factor: 5.532

4.  Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation.

Authors:  Livia A Veress; Heidi C O'Neill; Tara B Hendry-Hofer; Joan E Loader; Raymond C Rancourt; Carl W White
Journal:  Am J Respir Crit Care Med       Date:  2010-07-16       Impact factor: 21.405

Review 5.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

6.  Fibrinogen Is a Specific Trigger for Cytolytic Eosinophil Degranulation.

Authors:  Mackenzie E Coden; Lucas F Loffredo; Matthew T Walker; Brian M Jeong; Kiwon Nam; Bruce S Bochner; Hiam Abdala-Valencia; Sergejs Berdnikovs
Journal:  J Immunol       Date:  2019-12-09       Impact factor: 5.422

Review 7.  Pathological Roles of Neutrophil-Mediated Inflammation in Asthma and Its Potential for Therapy as a Target.

Authors:  Han Gao; Songmin Ying; Yuanrong Dai
Journal:  J Immunol Res       Date:  2017-11-22       Impact factor: 4.818

8.  Puerarin attenuates ovalbumin-induced lung inflammation and hemostatic unbalance in rat asthma model.

Authors:  Feng Dong; Chengbin Wang; Jinyan Duan; Weiyi Zhang; Daijun Xiang; Mianyang Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-02       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.